Similar articles

• Perspectives in the prevention and treatment of acute graft versus host disease.

  Herve P. Herve P. Bone Marrow Transplant. 1991;7 Suppl 2:117-9. Bone Marrow Transplant. 1991. PMID: 1715225 Review. No abstract available.
• Bone marrow transplantation for severe aplastic anaemia: cost/benefit of increased immunosuppression.

  Gordon-Smith EC. Gordon-Smith EC. Bone Marrow Transplant. 1991;7 Suppl 2:103-5. Bone Marrow Transplant. 1991. PMID: 1908725 Review. No abstract available.
• Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.

  Champlin R. Champlin R. Semin Hematol. 1992 Jul;29(3 Suppl 2):46-52. Semin Hematol. 1992. PMID: 1509294 Review. No abstract available.
• Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor.

  Tiley C, Powles R, Teo CP, Treleaven J, Findlay M, Hewetson M. Tiley C, et al. Bone Marrow Transplant. 1991;7 Suppl 2:151. Bone Marrow Transplant. 1991. PMID: 1652326 No abstract available.
• Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.

  Slavin S, Or R, Naparstek E, Weiss L, Mumcuoglu M, Weshler Z, Brautbar H, Cividalli G, Glikson M, Hale G, et al. Slavin S, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2614-5. Transplant Proc. 1987. PMID: 3274569 No abstract available.